19/12/2014 04:21:20 Free Membership Login

   

Ariad

Visual Financials
Company Name: Ariad Pharmaceuticals
Ticker Symbol: ARIA
WWW Address: http://www.ariad.com
CEO: Harvey Berger
No. of Employees: 300
Common Issue Type: CS
Business Description:Ariad Pharmaceuticals Inc is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

 
Industry Information: DRUGS - Biotechnology [more like this]
 Price  Day Change  Bid  Ask  Open  High  Low  Volume 
 6.615 Unchanged 0.0 5.96 6.82  6.70 6.45 -
 Market Cap (mil) Shares Outstanding (mil) Beta EPS DPS P/E Yield 52-Wks-Range
 1,238.4 187.2 0.00 -1.49 0.00 0.0 0.0 9.83 - 4.80
KEY FIGURES (Latest Twelve Months - LTM)
Yesterday's Close6.61$
PE Ratio - LTM0.0
Market Capitalisation1,238.4mil
Latest Shares Outstanding187.2mil
Earnings pS (EPS)-1.49$
Dividend pS (DPS)0.00¢
Dividend Yield0.0%
Dividend Payout Ratio%
Revenue per Employee$
Effective Tax Rate%
Float167.5mil
Float as % of Shares Outstanding0.9%
Foreign Salesmil
Domestic Salesmil
Selling, General & Adm/tive (SG&A) as % of Revenue3.20%
Research & Devlopment (R&D) as % of Revenue3.60%
Gross Profit Margin78.9%
EBITDA Margin-591.4%
Pre-Tax Profit Margin0.0%
Assets Turnover16.5%
Return on Assets (ROA)-99.5%
Return on Equity (ROE)-183.8%
Return on Capital Invested (ROCI)-131.1%
Current Ratio3.4
Leverage Ratio (Assets/Equity)2.0
Interest Cover-1788.0
Total Debt/Equity (Gearing Ratio)0.58
LT Debt/Total Capital36.0%
Working Capital pS0.92$
Cash pS0.00$
Book-Value pS0.43$
Tangible Book-Value pS0.99$
Cash Flow pS-0.98$
Free Cash Flow pS-1.01$
KEY FIGURES (LTM): Price info
Price/Book Ratio14.64
Price/Tangible Book Ratio0.00
Price/Cash Flow-6.4
Price/Free Cash Flow-6.3
P/E as % of Industry Group0.0%
P/E as % of Sector Segment0.0%
 
Balance Sheet (at a glance) in Millions
DIVIDEND INFO
Type of Payment-
Dividend Rate0.00
Current Dividend Yield0.0
5-Y Average Dividend Yield0.0
Payout Ratio0.0
5-Y Average Payout Ratio0.0
Share price performance previous 3 years

Share price performance intraday

 
PRICE/VOLUMEHighLowClose% Price Chg% Price Chg vs. Mkt.Avg. Daily VolTotal Vol
1 Week---7.658.35-12-2
4 Weeks6.706.456.457.658.35610
13 Weeks6.616.6154863256.029.83710
26 Weeks54863257.657.656.249.8372
52 Weeks6.036.036.577.654.1162
YTD4.804.80-7.654.90115
Moving Average5-Days10-Days10-Weeks30-Weeks200-DaysBeta (60-Mnth)Beta (36-Mnth)
4.904.905.765.767.650.720.72
 
GROWTH RATES5-Year
Growh
R² of 5-Year Growth3-Year
Growth
Revenue1454826917576390275763902
Income145482691145482691428847011
Dividend428847011881897912881897912
Capital Spending3084203838NA3084203838
R&D96993646NA96993646
Normalized Inc.428847011NA428847011
 
CHANGESYTD vs.
Last YTD
Curr Qtr vs.
Qtr 1-Yr ago
Annual vs.
Last Annual
Revenue %-8-34-34
Earnings %1414-25
EPS %979595
EPS $-257777
 
SOLVENCY RATIOS
SHORT-TERM SOLVENCY RATIOS (LIQUIDITY)
Net Working Capital Ratio0.00
Current Ratio370894000
Quick Ratio (Acid Test)125948000
Liquidity Ratio (Cash)0.00
Receivables Turnover472000
Average Collection Period
Working Capital/Equity
Working Capital pS
Cash-Flow pS
Free Cash-Flow pS185517000
FINANCIAL STRUCTURE RATIOS
Altman's Z-Score Ratio0.00
Financial Leverage Ratio (Assets/Equity)11363000
Debt Ratio185377000
Total Debt/Equity (Gearing Ratio)Sp
LT Debt/Equity8580000
LT Debt/Capital Invested0.0
LT Debt/Total Liabilities185377000
Interest Cover-40311000
Interest/Capital Invested0.00
 
VALUATION RATIOS
MULTIPLES
PQ Ratio0.00
Tobin's Q Ratio0.00
Current P/E Ratio - LTM888,167,623.00
Enterprise Value (EV)/EBITDA0.00
Enterprise Value (EV)/Free Cash Flow-1.68
Dividend Yield21687156
Price/Tangible Book Ratio - LTM178
Price/Book Ratio - LTM12371313
Price/Cash Flow Ratio3.4
Price/Free Cash Flow Ratio - LTM178
Price/Sales Ratio-9.00
P/E Ratio (1 month ago) - LTM888167623
P/E Ratio (26 weeks ago) - LTM1510237232
P/E Ratio (52 weeks ago) - LTM1510237232
5-Y High P/E Ratio3129942374
5-Y Low P/E Ratio2642949198
5-Y Average P/E Ratio6591314
Current P/E Ratio as % of 5-Y Average P/E6591314
P/E as % of Industry Group7,274,134.0
P/E as % of Sector Segment7,274,134.0
Current 12 Month Normalized P/E Ratio - LTM6,887,627.0
PER SHARE FIGURES
LT Debt pS99412000
Current Liabilities pS
Tangible Book Value pS - LTM3.4
Book Value pS - LTM12371313
Capital Invested pS0.00
Cash pS - LTM156038
Cash Flow pS - LTM4.56
Free Cash Flow pS - LTM4.56
Earnings pS (EPS)729
 
OPERATING RATIOS
PROFITABILITY RATIOS
Free Cash Flow Margin0.00
Free Cash Flow Margin 5YEAR AVG0.00
Net Profit Margin-40311000
Net Profit Margin - 5YEAR AVRG.2014-10-31
Equity Productivity0.00
Return on Equity (ROE)185517000
Return on Equity (ROE) - 5YEAR AVRG.1186926793
Capital Invested Productivity0.00
Return on Capital Invested (ROCI)
Return on Capital Invested (ROCI) - 5YEAR AVRG.-96
Assets Productivity11,363,000.00
Return on Assets (ROA)
Return on Assets (ROA) - 5YEAR AVRG.1186926793
Gross Profit Margin7274134
Gross Profit Margin - 5YEAR AVRG.-96
EBITDA Margin - LTM6597646
EBIT Margin - LTM7274134
Pre-Tax Profit Margin108777000
Pre-Tax Profit Margin - 5YEAR AVRG.187212428
Effective Tax Rate100.0
Effective Tax Rate - 5YEAR AVRG.100.0
EFFICIENCY RATIOS
Cash Conversion Cycle72,177,242
Revenue per Employee
Net Income per Employee968,000
Average Collection Period
Receivables Turnover472000
Day's Inventory Turnover Ratio72177000
Inventory Turnover472000
Inventory/Sales99412000
Accounts Payble/Sales0.00
Assets/Revenue0.00
Net Working Capital Turnover0.00
Fixed Assets Turnover0.00
Total Assets Turnover11363000
Revenue per $ Cash41006000
Revenue per $ Plant41006000
Revenue per $ Common Equity
Revenue per $ Capital Invested
Selling, General & Adm/tive (SG&A) as % of Revenue
SG&A Expense as % of Revenue - 5YEAR AVRG.187212428
Research & Devlopment (R&D) as % of Revenue
R&D Expense as % of Revenue - 5YEAR AVRG.

  


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nasdaq aria141219 04:21